Tagungen und Workshops zum Thema Onkologie

Der Fokus des ersten Veranstaltungstages liegt im Bereich Diagnostik, während am zweiten Tag die Therapie und Therapiemöglichkeiten in den Mittelpunkt gerückt werden. In Übersichtsvorträgen, geleitet von renommierten Referenten, sollen die neusten Diagnostik- und Therapiemöglichkeiten vorgestellt werden. Dem LHOS vorgeschalten ist ein Diagnostikkurs, der sich an Ärztinnen und Ärzte in Weiterbildung zum Hämatologen/Onkologen, Medizinisch-Technisches Personal und auch an interessierte Mitarbeiter der Pharmaindustrie richtet, die einen umfassenden Überblick zu aktuellen Standards in der Diagnostik von Leukämien und Lymphomen vermittelt bekommen. Neben der Lehrmikroskopie werden Übersichtsvorträge von erfahrenen Hämatologen gehalten sowie interessante Kasuistiken vorgestellt. Der Kurs wird mit einem Zertifikat abgeschlossen und ist mit 26 Weiterbildungspunkten der Kategorie C zertifiziert. Parallel erhalten die Teilnehmer des Diagnostikkurses die Möglichkeit den LHOS ohne zusätzliche Gebühren zu besuchen.

Tel.: [+49 (0)341 308884 – 82];     Email: kschmidt@eventlab.org

Hämatologie, Onkologie, Zytogenetik, MRD-Diagnostik, Biomarker, Mantelzelllymphom, Hämostaseologie, Multiples Myelom, Chemotherapie, Schwangerschaft, kolorektales Karzinom

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

UT Health San Antonio

Official Best of SABCS® highlights programs to be held in the United States in 2020 reviewing most SABCS® 2019 relevant advances in breast cancer management.

Tel.: [+1 443-370-2698];     Email: Michele.dinkel@encoremeded.com

breast cancer, oncology, cancer

Chirurgie,    Radiologie:Mammografie

Unique in Europe, the TOW (Toulouse Onco Week) invites you to its third edition, from February 1st to 5th, 2020! Organized as part of the World Cancer Day, TOW is unique as to bring together the different actors from research, care, industry and charities in order to better fight cancer. In February 2018, this meeting brought together more than 2 000 participants and was the opportunity for a strong mobilization of the medical and scientific community and hopeful announcements.

Insight Outside;     Email: contact@toulouse-onco-week.org

Can we really improve DNA damaging agents efficacy? Targeted therapies and resistance mechanisms Translating oncoimmunology science into survival Metabolic vulnerabilities–driven therapies

Unique en Europe, la TOW (Toulouse Onco Week) vous donne rendez-vous pour sa troisième édition, du 1er au 5 février 2020! Organisée dans le cadre de la journée mondiale contre le Cancer, la TOW a la particularité de fédérer les acteurs scientifiques, médico-soignants, industriels et associatifs pour mieux combattre le cancer. En février 2018, cette rencontre a réuni plus de 2000 participants et a été l’occasion d’une forte mobilisation de la communauté médico-scientifique et d’annonces porteuses d’espoir.

Tel.: [0585954554];     Email: soizic@toulouse-onco-week.org

Can we really improve DNA damaging agents efficacy? Targeted therapies and resistance mechanisms Translating oncoimmunology science into survival Metabolic vulnerabilities–driven therapies

ESMO’s Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types. The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities.The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.

Tel.: [+41 91 97 31 939];     Email: registration@esmo.org

sarcoma, gist, gastrointestinal stromal tumours, rare cancers, translational research, oncology, cancer, soft tissue sarcomas, medical oncology, surgical oncology, radiotherapy, pathology

UT Health San Antonio

Official Best of SABCS® highlights programs to be held in the United States in 2020 reviewing most SABCS® 2019 relevant advances in breast cancer management.

Tel.: [+1 443-370-2698];     Email: Michele.dinkel@encoremeded.com

breast cancer, oncology, cancer

Chirurgie,    Radiologie:Mammografie

Evading programmed cell death is a major hallmark of cancer cells and contributes to tumor progression and therapy resistance. Emerging hallmarks such as metabolic plasticity, genomic instability and an immunosuppressive tumor environment allow the tumors to escape from standard cytotoxic as well as targeted therapies. Thus, understanding the underlying mechanisms in appropriate pre-clinical/clinical models is crucial for the design of more effective combination therapies to avoid treatment failure or tumor recurrence. The EACR Special Conference “A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities” is the 5th Conference on this topic. Its objective is to cover recent and exciting developments in the field of cancer research that are crucial to our understanding of the multifaceted role of cell death in tumor initiation, progression and therapy response.

The 4th DNA Repair/Replication Structures & Cancer conference in February 2020 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. This fundamental information will be pivotal for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently 1/20 low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations.

Conference Manager;     Tel.: [+441638724137];     Email: admin@fusion-conferences.com

DNA, DNA Repair, DNA replication, RNA, Cancer, DNA damage signaling, cross-talk, Epigenetics, PARP, PARG, metabolic signalling, Mitochondrial replication, apoptosis

Molekularbiologie,    Biologie

Oxford Global

Tel.: [+441865248455];     Email: g.alonso@oxfordglobal.co.uk

Biomarkers, Precision Medicine, Drug Development, Bioinformatics, Genomic Markers

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Tel.: [+49 3643 2468-0];     Email: info@kukm.de

Hilaris Conference invite you to be a part of the Oncology conference in Paris, France on February 20-21, 2020 to discuss on the new innovations within the field of Oncology for providing a much better moreover as a healthier life for the individuals from exceptionally prominent people and display of Standard universities.Hilaris Conference on Oncology 2020 pleased to be able to invite those of you ready to share their knowledge towards Oncology as well as those who are knowledge gaining aspirants in a single stage.

Tel.: [359-825-18874];     Email: oncologymeet@gmail.com

Oncology conferences, Cancer Conferences 2020, Oncology 2020, Oncology Meeting, symptoms of Cancer, Radiology, Cancer meeting, Breast cancer treatment, About pcos, Cancer conferences in Paris, France, Cancer research, Hilaris Conference

Fusion Conferences Ltd

This meeting aims to present the most recent advances in the mechanistic understanding of DNA metabolic processes at the single-molecule level, using both in vivo and in vitro approaches.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

DNA replication, DNA recombination, DNA repair, Transcription, Chromosome dynamics, Genomics

Molekularbiologie,    Biologie

Secretariat;     Tel.: [+82-2-566-6031];     Email: ik2020@iasgo-ksgc2020.org

Esophagus, Stomach, Colon, Pancreas, Liver and Bile Duct, Small Intestine, Basic Translation, Others

Gastroenterologie,    Chirurgie

Deutsche Krebsgesellschaft e. V., Stiftung Deutsche Krebshilfe, Berliner Krebsgesellschaft e. V.

Informationsaustausch über neueste Erkenntnisse rund um das Thema Krebs mit zahlreichen Informationsständen - Erfahrungsaustausch von Experten und Betroffenen über Aktuelles zu den Erkrankungen - Gespräche mit Experten, Selbsthilfeorganisationen sowie anderen Betroffenen und Angehörigen

Deutsche Krebsgesellschaft e. V., Stiftung Deutsche Krebshilfe, Berliner Krebsgesellschaft e. V.;     Tel.: [+49 30 3229329-0, +49 228 72990-0, +49 30 28324-00];     Email: service@kfrebsgesellschaft.de, deutsche@krebshilfe.de, info@berliner-krebsgesellschaft.de

Informationsveranstaltung zu aktuellen Erkrankungen wie Brust-, Prostata-, Darm-, Lungen-, Blasen-, Nieren- und Hautkrebs, Leukämie, Lymphome, Hirn- und gynäkologischen Tumoren..., Selbsthilfe, Betroffene, Angehörige, Psychische und soziale Belastungen, Erfahrungsaustausch, Krebskongress

Fusion Conferences Ltd

This unique meeting will bring together many of the leading figures in nuclear receptor research from across the globe, to discuss emerging roles and their implications for health and disease – and both human and drug development – in an intimate meeting that will generate meaningful idea exchange and interaction that will help to further shape this influential field.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

Nuclear receptors and cancer, Nuclear receptors in reproduction, development and metabolism, Nuclear receptors in central systems, Translating nuclear receptors to the clinic, Nuclear receptors in non-malignant disorders, New advances in nuclear receptors research

Molekularbiologie,    Biologie

MedStar Georgetown University Hospital

The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery and the role of prophylactic mastectomy. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and neoadjuvant chemotherapy and its role in restaging breast cancer. Additionally, the program will examine nipple-sparing mastectomy, both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema. The latest updates on national trends and data on financial toxicity related to cancer care will also be discussed.

Registrar;     Tel.: [202-780-1655];     Email: MedStarBC3@gmail.com

Fusion Conferences Ltd

This meeting on "Epigenetics: from mechanisms to disease" will bring together scientists studying chromatin architecture, epigenetics, stem cell biology and cancer. The talks will cover a broad range of topics, including chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation/differentiation, RNA-based mechanisms, transcription regulation, DNA methylation and hydroxymethylation.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

chromatin architecture, epigenetics, stem cell biology, cancer, chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation, stem cell differentiation, RNA-based mechanisms, transcription regulation, DNA methylation, hydroxymethylation

Molekularbiologie,    Genomforschung und Bioinformatik

UT Health San Antonio

Official Best of SABCS® highlights programs to be held in the United States in 2020 reviewing most SABCS® 2019 relevant advances in breast cancer management.

Tel.: [+1 443-370-2698];     Email: Michele.dinkel@encoremeded.com

breast cancer, oncology, cancer

Chirurgie,    Radiologie:Mammografie

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO)

This EACR-AACR-ASPIC conference on Tumor Microenvironment(TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems.

Email: hello@eaa2020.org

Tumour Microenvironment, Immune-oncology, Computational biology

Thomas Jefferson University, Office of Continuing Professional Development

This two-day course is designed for healthcare professionals whose practices focus on the screening, diagnosis, management, and treatment of lung cancer using a multidisciplinary approach. This symposium is led by experts in the fields of Medical and Radiation Oncology, Surgery, Population Health, and Pulmonary Medicine. Day one highlights advances in lung cancer screening and a health equity perspective to screening services. Day one concludes with a discussion of surgical approaches and immunotherapy for the practicing physician. Day two starts off with a scholarly discourse of oligometastases in lung cancer and MRI-Guided radiation. Day two will also engage you in lively, interactive case-based discussions, a mock tumor board, and critical deliberations on the state of current knowledge, clinical approaches, differential diagnoses, and management options for lung cancer.

Jefferson CPD;     Tel.: [215-955-6992];     Email: jeffersoncpd@jefferson.edu

cme, philadelphia, oncology, cancer, lung cancer,

Lungenheilkunde,    Fortbildung für Gesundheitsfachberufe (CME)

The 3rd International Cancer Congress (ICC 20) is an educational meeting intended to improve the care of cancer patients in South Asia by educating cancer care providers about the latest developments in the field of cancer, and their applications in local context. This international hematology and oncology conference will feature renowned faculty from the United States, Nepal, and other parts of the world.

The aim of the study day is to facilitate and equip attendees with the knowledge and skills to care for those with communication and swallowing disorders as a result of their oncological diagnosis or treatment.

Conference Team;     Tel.: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Invivox - Peer-to-peer medical training

This Masterclass is intended for surgeons who want to discover best practices in Colorectal Surgery and learn the strategic rationale behind the technique. Pr. Rullier and Dr Denost will welcome 24 Experts (to be confirmed soon) and host 14 Live Cases with each day dedicated to a specific subject: Colon Cancer, Rectal Cancer, Benign Disease, and Pelvic Floor Disorders. This unique 5-day course will address standards and innovative techniques for colorectal surgery. All pathologies will be transversally covered and we will present the best medical-surgical strategies to understand the holistic management of the disease.

Tel.: [+33 6 38 56 35 36];     Email: sholcher@invivox.com

pelvicare, colorectal surgery courses, colorectal masterclass, colon cancer, rectal cancer, pelvic floor disorders

Chirurgie,    Fortbildung für Gesundheitsfachberufe (CME)

Duke University Health System Department of Clinical Education and Professional Development

Join an outstanding roster of national urologists, oncologists, and radiologists participating in a comprehensive scientific program that encompasses leading edge updates on the most effective and efficient diagnoses and treatments in the sub-specialties of urology.

Knowing how cells respond to DNA damage is critical to our understanding of tumourigenesis, genomic instability, and the cellular response to DNA-damaging chemotherapy and radiotherapy. DNA damage responses take place in the context of chromatin and in the midst of ongoing transcription and replication. Moreover, the metabolic environment, which is altered in tumour cells, influences these activities. In this conference, we aim to bring together researchers working on understanding DNA damage responses in the context of complex and dynamic cellular environments. This is an exciting and fast moving area, and this conference features an excellent international line-up of speakers. The programme will address the challenges of understanding this complex field and will emphases new experimental approaches for interrogating these pathways. We will also consider how recent advances can be exploited in the clinic.

DNA damage responses, cancer, oncology, Epigenetic, radiotherapy, transcription, immune, repair, tumourigenesis, cellular, genomic

ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

WMA GmbH Congress Office;     Tel.: [+431405138318];     Email: itoc@medacad.org

Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy

Immunologie und Allergie,    Pharmakologie und Arzneimittelentwicklung

Binaytara Foundation

The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer care. The summit will feature lectures, discussions and presidential-style debates among leaders across the spectrum of healthcare delivery. It is our hope that this summit will lead us in a direction to help thousands of cancer patients and their families who are still deprived of cutting-edge cancer treatment.

Tel.: [4255575953];     Email: support@binayfoundation.org

Thomas Jefferson University, Office of Continuing Professional Development

The 2nd Annual Head and Neck Cancer Symposium: A Multidisciplinary Approach offers participants an active learning format featuring didactic lectures, panel discussions that will include audience interaction, patient cases, and updates on clinical findings on diagnosis, treatment and management plans for patients with head and neck cancer. Participants will be able to examine head and neck cancer cases from multiple perspectives with a multidisciplinary approach to care.

Jefferson CPD;     Tel.: [2159556992];     Email: jeffersoncpd@jefferson.edu

oncology, head and neck cancer, cancer, cme, philadelphia

Hals-Nasen-Ohren-Heilkunde,    Fortbildung für Gesundheitsfachberufe (CME)

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

Epigenetics, Cancer, Chromatin regulatory pathways, RNA modification pathways, DNA modification pathways, Drug discovery

Genomforschung und Bioinformatik,    Pharmakologie und Arzneimittelentwicklung

The University of Texas MD Anderson Cancer Center & Peter MacCallum Cancer Centre

MD Anderson Cancer Center - Global Academic Programs (GAP) 2020 Conference is a forum where MD Anderson Cancer Center and its global network of hospitals, health systems and research institutions collaborate to develop impactful, innovative ideas and research that help MD Anderson achieve its mission to end cancer globally. This three-day scientific conference centres our attention on the theme – New Frontiers – Leading Inspired Cancer Care. We are looking forward to highlighting global collaborations that bring to light clinical and translational research, population health and government engagement initiatives.

Tel.: [03 6234 7844];     Email: jodi@laevents.com.au

Immunology | The Leading Frontier, Tele Trials, Shared Care, Beyond the Walls | Maintaining a Work / Life Balance, Surviving Translation | Keeping up and Connecting, Facing the Future | Robotics, AI, Deep Machine Learning, Prehabilitation

Justus-Liebig-Universität Gießen

We proudly and cordially invite you to the upcoming „4th International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma“ to be held 13-16 May, 2020 in Berlin, Germany. This important symposium has now almost become a tradition for scientists, clinicians, pharmacists, clinical trial staff, and all people who are involved in the science, diagnosis, and treatment of young people with Hodgkin lymphoma. We are putting together, in collaboration with our fantastic Scientific Committee, a high-quality program with renowned international speakers and experts in the field of Hodgkin lymphoma. We will have two and a half days dedicated to ten main Session Topics, who are now open for abstract submission. We will have interactive case discussions as an opener of most session topics. High-level poster presentations will have the opportunity to advertise their poster via poster pitches in the respective main sessions. One of the highlights will be the awarding of the Günther-Schellong-Price, which will be conferred for the third time. The Scientific Symposium will close with the Abstract Award Session. It is our utmost pleasure to serve again with a major symposium for this great global network for advancing the science and development of standards of care for children, adolescents and young adults with Hodgkin lymphoma. Thus, your attendance at the symposium, will contribute for this well-established network to continue, and you will have the chance to experience the spirit and the action that this great collaboration enables in providing long-lasting cures for all children, adolescents and young adults with Hodgkin lymphoma.

Conference office / Registration;     Tel.: [+49 40 30770 300];     Email: iscayahl@csihamburg.de

advancing science, advancing development, standards of care for children, adolescents and young adults with Hodgkin lymphoma, Hodgkin lymphoma, diagnosis and treatment of young people with Hodgkin lymphoma

Over the last few years, the myeloma field has made significant progresses. We have seen fascinating novel drugs being introduced (including innovative cellular therapies), and the whole treatment paradigm is progressively changing.

Like the previous ones, this international meeting aims to deliver state of the art science and research, focused on the latest advances in the field and on improving patient care.

The scientific content will be on the cutting-edge one because the pace of change in multiple myeloma is accelerating.

In addition to the science, you will be able to enjoy this most spectacular city of Paris. We are looking forward to seeing you in Paris next year

Tel.: [+972528887612];     Email: moran@cme-congresses.com

Multiple Myeloma, cancer, CAR T Cell

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Molecular pathology is revolutionising clinical practice in oncology and pathology paving the way for precision medicine, and has evolved into a growing research field. Knowledgeable molecular pathologists are a significant bottle neck for advancing cancer research and patient care. This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

Email: laura.strachan@eacr.org

Molecular pathology, cancer research, oncology

Oxford Global Conferences

Immuno-Oncology, Cancer Immunology, Cancer Vaccines, Immunotherapy, Oncology Cell Therapy, Antibody Development, T-Cell Engineering, Immune Biology, Combination Therapy, CAR-T Cell Therapy, Checkpoint Inhibitors, Bispecific, Assay Development, Cancer Genetics/Genomics, Personalised Medicine, Biomarker, Translational Immunology, Preclinical Development, Clinical Oncology, Clinical Trial Management, Clinical Development

German Cancer Reseach Center Heidleberg (DKFZ) and University Hospital Heidelberg

The fast technological development and the rapid clinical implementation of MRI for radiotherapy applications is currently one of the most exciting as well as most challenging developments in radiation oncology. With this science symposium we would not only like to bring together specialists from all involved disciplines, but also to foster a discussion about the scientific direction of the field. The latest developments in physics and technology of MR-guided radiotherapy as well as clinical directions and results will be presented.

Tel.: [+49 6221 423481];     Email: mrinrthd@dkfz-heidelberg.de

MR guidance, image guidance, adaptive radiotherapy, MR imaging, functionall imaging and others

Biophysik,    Radiologie:Kernspintomographie

Wir freuen uns sehr, Sie zur 3. gemeinsamen Jahrestagung der Mitteldeutschen Gesellschaft für Gastroenterologie (MGG) und der Mitteldeutschen Chirurgenvereinigung (MDCV), dem 3. Mitteldeutschen Pflegesymposium und dem 9. Symposium Junge Chirurgen in Mitteldeutschland in Dresden zu begrüßen. Nach den erfolgreichen gemeinsamen Kongressen 2018 in Leipzig und 2019 in Halle wollen wir das interdisziplinäre Profil des wissenschaftlichen Programms weiter stärken. Gemäß unserem Kongressmotto „Innovationen für die Praxis“ haben wir zeitgemäße Themenschwerpunkte in den Bereichen innovativer operativer und gastroenterologischer Therapien, der Onkologie, bei seltenen und bei entzündlichen Erkrankungen des Gastrointestinaltrakts, sowie dem immer relevanteren metabolischen Syndrom gesetzt. Besonders wichtig ist es uns, die Interessen der jungen Chirurgen und jungen Gastroenterologen in unserem Programm abzubilden. Wir freuen uns auf Ihre zahlreiche Teilnahme in den dezidierten Sitzungen und praktischen Workshops unter anderem in den Bereichen Robotik, Naht und Darmsonographie. Herausragende Leistungen würdigen wir traditionell durch die im Rahmen des Gesellschaftsabends verliehenen Posterpreise. Wir finden, Viszeralmedizin ist Teamwork. Daher steht die Einbeziehung der Pflege mit dem bewährten Pflegesymposium wieder auf dem Programm und soll in interdisziplinären Workshops weiter gestärkt werden.

event lab. GmbH;     Tel.: [0341-30888464];     Email: tbaehr@eventlab.org

Gastroenterologie, Chirurgie, Onkologie, Robotik und Digitalisierung, Darmsonographie, Naht, Viszeralmedizin, Kolorektales Karzinom, Pankreaskarzinom, Leberversagen, CED, Endoskopische Innovationen, Tracheo/ Bronchoösophageale Fisteln, Unfallchirurgie, Kinderchirurgie, Gefäßchirurgie, Viszerale Palliativmedizin, Chronische Pankreatitis, Refluxerkrankungen

Gastroenterologie,    Chirurgie

wikonect GmbH

The management of cholangiocarcinoma remains a major challenge. With the establishment of modern surgical, interventional and systemic treatment options over the last few years, the treatment of cholangiocarcinoma more than ever requires an interdisciplinary approach and open dialogue. Therefore, the 3rd International Expert Meeting in Mainz will bring together renowned specialists in the field of surgery, medical oncology, pathology, endoscopy, diagnostic and interventional radiology as well as radiotherapy. Experts from all around the world will meet in Mainz for an intensive two-day discussion on diverse aspects of cholangiocarcinoma. The program 2020 comprises most relevant topics and critical issues on the diagnosis and management of intrahepatic, perihilar as well as distal cholangiocarcinoma: as observed in other cancer types, molecular profiling has started to gain increasing relevance in the treatment of advanced cholangiocarcinoma. Moreover, novel diagnostic approaches as well as tools for local therapy have been developed, which require particular attention. Furthermore, controversies on the optimal preoperative work-up including biliary drainage as well as potential indications for neoadjuvant and adjuvant targeted therapy will be major topics. Also, IgG4-associated cholangitis and Klatskin-mimicking lesions that are still highly difficult differential diagnoses and pose major therapeutical problems will be highlighted. Finally, operative techniques, pitfalls in surgery and surgical strategies are presented focusing on vascular resection, the laparoscopic and robotic approach as well as ALPPS.

wikonect GmbH;     Tel.: [+49 611 204 809 242];     Email: info@wikonect.de

Chirurgie,    Radiologie (allgem.)

EACR 2020 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Email: hello@eacr2020.org

Artificial Intelligence, Cancer Genomics, Immuno Genomics, Cancer Models, Metastasis, Lineages, DNA Damage, Vital Imaging, Metabolism, Microbes

MCI Deutschland GmbH

Organizer;     Tel.: [+49 30 204590];     Email: degro@mci-group.com

Ultra-High Dose Rates, Hypofractionation in curative therapy, Oligoma Tastasis, Synergies with Immunotherapy, Artificial Intelligence and Radiomics, MRI-guided Radiation Therapy, DEGRO: The First 25 Years; the next 25 years, Brachytherapy: Status and Development

ICECT 2020

International Conference and Exhibition of Cancer & Therapeutics" (Cancer London 2020) invites all the delegates to our upcoming conference which is going to be held in London, UK during July 6 - 8, 2020. The theme of ICECT 2020 conference is “Cancer Current Research & Treatments

Email: cancer_cong@cancerlondonconf.com

Cancer London 2020

This conference will focus on three major areas: First, it will present new approaches to generate precise and complex genetic alterations in mice and other animals to better “humanize” models and allow for in vivo studies of cancer gene function. Second, it will highlight studies to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system. Finally, the meeting will explore how genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

New technologies for cancer modelling, Modeling pre-cancers and tumor initiation, Cancer metabolism, Cancer/immune interactions and tumor microenvironment, Metastasis, Preclinical trials and resistance, Oncology, Animal Modeling

Biologie,    Translationale Medizin, Klinische Studien

European Association for Cancer Research & European Society of Oncologic Imaging

This new conference is organised by the European Association for Cancer Research (EACR) and the European Society of Oncologic Imaging (ESOI).Our ability to understand and treat cancer is critically dependent upon imaging. This meeting will bring together imaging experts in both clinical and basic research arenas to present their latest research and discuss how to integrate understanding across length scales, imaging modalities, and cancer types. Improved clinical imaging has the power to transform the detection and biologic characterisation of early lesions and the identification of those patients with more advanced disease for tailoring and monitoring personalised therapies. Further, the development of new therapies depends on improved understanding of cancer biology; small animal imaging and imaging tumours with cellular and sub-cellular resolution can elucidate heterogeneity in cancer cell state and interactions with stromal cells, which provide new opportunities for therapeutic intervention. This conference is aimed at clinical and experimental cancer researchers working with, or interested in, the broad range of imaging modalities including US and photoacoustic, CT and micro CT, MRI, PET/CT and PET/MR hybrid imaging, as well as optical techniques. Data analysts dealing with imaging data science using deep learning/machine learning, are also explicitly encouraged to attend.

Email: claire.sullivan@eacr.org

Imaging, Oncology, Machine Learning, Deep Learning, Cancer Biology, Personalised Therapies

The eighth annual meeting of the Society of Hematologic Oncology (SOHO 2020) is scheduled for September 9–12, 2020 at the Hilton Americas, 1600 Lamar St, Houston, Texas 77010. Organized by its founders and world class committees, SOHO is the only international society specific to the field of hematologic malignancies.

Tel.: [+4936413116390];     Email: conferencemarketing@conventus.de

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide hands-on experience in the several techniques to detect and analyse circulating tumor cells (CTCs), cell free tumor DNA (ctDNA) and proteins. Participants will have the opportunity to learn all aspects ranging from proper sampling through error free sequencing to data analysis. Lectures will also cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics.

EMBL Events;     Tel.: [+49 6221 378 8797];     Email: events@embl.de

Hands-on experience on ultra-sensitive mutation detection using sequencing, Applications of digital PCR to the liquid biopsy workflow, Protein analysis in liquid biopsis, Data analysis and interpretations

Medizin (allgem.),    Analysis

Tel.: [+4936413116390];     Email: conferencemarketing@conventus.de

We are delighted to invite you to participate in the 3rd Annual Meeting of the International Academy for Clinical Hematology (IACH): Focus on Leukemia, taking place October 1-3, 2020 in Nice, France.Our 3rd edition will focus on leukemia in a format that allocates a significant amount of time to interactive debates and audience questions to the expert panels. Participants are encouraged to take an active role in the discussions with faculty members in this unique open environment.

Tel.: [+972528887612];     Email: moran@cme-congresses.com

Leukemia, CAR T Cell therapy

Hämatologie,    Stammzellforschung und -therapie

The 2nd EACR Conference on Mechanisms to Therapies: Innovations in Cancer Metabolism will gather top experts in the field to discuss the metabolic alterations in tumours and how we can exploit it to treat cancer.

Email: laura.strachan@eacr.org

Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Cancer Center of the University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. This year’s conference will focus on tumor microenvironment, cell-based therapy in hematology and oncology, immune checkpoint inhibitors, biomarkers, cell therapies and cancer vaccines.

Fraunhofer Institute for Cell Therapy and Immunology;     Tel.: [+49 341 35536-9320];     Email: info@lion-conference.com

oncology, immunology, hematology, biomarkers, immunotherapy, cell therapies, cancer vaccines

Immunologie und Allergie,    Hämatologie

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.)

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.) is organising the second New Zealand Breast Cancer Symposium in 2020 (NZBCS-2020), which will be held in Auckland, New Zealand from 12-14th November 2020.

Chair, the Organising Committee of NZBCS-2020;     Tel.: [0064-9-921 9999];     Email: nzbcs@aut.ac.nz

Breast Cancer, New Zealand, NZBCS, NZBCS-2020, NZABCR, Auckland, Symposium, Biomarker, Targeted Therapy, Immunotherapy

European Association for Cancer Research

This meeting aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.

Email: claire.sullivan@eacr.org

Liquid Biopsies, Biopsies, Tumor cells, Early detection of cancer, nucleic acids, biomarkers

Tel.: [+4936413116390];     Email: julia.wrenczycki@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de